Stock screenerAll disclosures →
EDGAR →
CLDX
Conviction 100HealthcareScan · Mon, Aug 10, 2026CLDX$42.98+3.04%
ResistanceSupportVol 14Vol MA14 1.13M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price42.98
Change+3.04%
Gap+1.25%
Rel volume2.69×
Avg volume1.06M
Avg $ vol40.02M
SMA 2037.66
SMA 5035.26
SMA 20030.06
Price vs 50+21.88%
Price vs 200+43.00%
MA stackbullish
50/200 cross—
Supertrendup · 37.51
RSI (14)76
MACD hist0.55
MACD crossbull · 5d
Stoch %K / %D98 / 94
ADX (14)30
+DI / −DI33 / 11
RSI divergence—
MACD divergence—
ATR %+3.73%
ADR %4.34%
52w high42.98
52w low20.01
From 52w high+0.00%
Above 52w low+114.79%
New 52w highYes
SqueezeOff
Bollinger width26.22%
%B1.04
Donchian pos97.96%
Donchian high43.18
Donchian low33.37
AVWAP (52w high)42.56
vs AVWAP high+0.99%
AVWAP (52w low)28.99
vs AVWAP low+48.26%
OBV trendUp
Chaikin MF (20)0.24
Today vs 20d2.69×
Avg vol (14d)1.13M
Avg vol (20d)1.06M
Avg $ vol (20d)40.02M
Market cap—
RS 3m (vs SPY)+19.48%
RS 6m (vs SPY)+70.61%
RS line new highYes
Trend template8/8
Technical rank92.4
1 week+14.04%
1 month+9.90%
3 months+26.52%
6 months+80.89%
1 year+102.64%
YTD+59.13%
P/E-12.66
P/B4.58
P/S—
P/FCF-15.33
EPS-3.90
Div yield—
ROE-36.21%
ROA-33.07%
Debt/Eq—
Current11.82
EV/EBITDA-11.37
Gross margin—
Net margin—
Rev growth-77.99%
EPS growth-63.91%
Price target58.79
Target upside40.92%
Analyst ratingBuy
Institutional104.04%
Ent. value3.23B
Revenue22K
Net income-73.5M
Gross profit—
Free cash flow-213.66M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out78.49M
Employees198
ListedThu, May 15, 1986
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank92.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance39.76
Support32.82
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Breaking out nowJun 24 – Jun 252 scans
- Setting upJul 14 – Jul 152 scans
Congress activity
Disclosed STOCK Act trades in CLDX
No recent disclosed trades by Congress in CLDX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CLDX · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Jain Rita Director · Non-Qualified Stock Option (right to buy) · 2026-06-25 | Grant | 26K | — | 2026-06-25 | 2026-06-29 |
Torres Denice Director · Non-Qualified Stock Option (right to buy) · 2026-06-25 | Grant | 26K | — | 2026-06-25 | 2026-06-29 |
KELER TIBOR EXECUTIVE VP & CSO · Incentive Stock Option (right to buy) · 2026-06-25 | Grant | 115K | — | 2026-06-25 | 2026-06-29 |
CONRAD HERBERT J Director · Non-Qualified Stock Option (right to buy) · 2026-06-25 | Grant | 26K | — | 2026-06-25 | 2026-06-29 |
Martin Samuel Bates SVP AND CFO · Incentive Stock Option (right to buy) · 2026-06-25 | Grant | 93K | — | 2026-06-25 | 2026-06-29 |
Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS · Incentive Stock Option (right to buy) · 2026-06-25 | Grant | 95K | — | 2026-06-25 | 2026-06-29 |
Brownlie Keith L Director · Non-Qualified Stock Option (right to buy) · 2026-06-25 | Grant | 26K | — | 2026-06-25 | 2026-06-29 |
Cavanaugh Sarah SVP OF CORP AFFAIRS & ADMIN. · Incentive Stock Option (right to buy) · 2026-06-25 | Grant | 95K | — | 2026-06-25 | 2026-06-29 |
PENNER HARRY JR Director · Non-Qualified Stock Option (right to buy) · 2026-06-25 | Grant | 26K | — | 2026-06-25 | 2026-06-29 |
MARINO JAMES J Director · Non-Qualified Stock Option (right to buy) · 2026-06-25 | Grant | 26K | — | 2026-06-25 | 2026-06-29 |
SEC filings
EDGAR filings in CLDX · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.